FATE vs VOO
Fate Therapeutics Inc (FATE) versus VOO (VOO) — a side-by-side from cached financials, not a winner call.
Fate Therapeutics Inc (FATE) is a biotechnology company listed on US.
VOO (VOO) common stock.
Latest reported FATE revenue for 2026-06-30 was $3.4M. Net income was -$61.4M. FATE currently screens at market cap $331.0M.
VOO does not have a complete income-statement cache yet.
FATE currently screens at market cap $331.0M. VOO currently screens at market cap $0.
Not investment advice. Open the FATE and VOO stock pages for the full models.
Not investment advice.